128 related articles for article (PubMed ID: 6148733)
1. Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
Löfdahl CG; Svedmyr K; Svedmyr N
Pharmacotherapy; 1984; 4(4):205-10. PubMed ID: 6148733
[TBL] [Abstract][Full Text] [Related]
2. Ventilatory effects of atenolol and bevantolol in asthma.
Lammers JW; Folgering HT; van Herwaarden CL
Clin Pharmacol Ther; 1985 Oct; 38(4):428-33. PubMed ID: 4042527
[TBL] [Abstract][Full Text] [Related]
3. Pafenolol, a highly selective beta 1-adrenoceptor-antagonist, in asthmatic patients: interaction with terbutaline.
Löfdahl CG; Marlin GE; Svedmyr N
Clin Pharmacol Ther; 1983 Jan; 33(1):1-9. PubMed ID: 6129091
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients.
Philip-Joet F; Saadjian A; Bruguerolle B; Arnaud A
Eur J Clin Pharmacol; 1986; 30(1):13-6. PubMed ID: 2872059
[TBL] [Abstract][Full Text] [Related]
5. Assessment of bronchial beta blockade after oral bevantolol.
Mackay AD; Gribbin HR; Baldwin CJ; Tattersfield AE
Clin Pharmacol Ther; 1981 Jan; 29(1):1-6. PubMed ID: 6109585
[TBL] [Abstract][Full Text] [Related]
6. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N
Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204
[TBL] [Abstract][Full Text] [Related]
7. Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Respir Dis; 1981 Dec; 62(6):396-404. PubMed ID: 6751838
[TBL] [Abstract][Full Text] [Related]
8. Acute, short- and long-term efficacy of oral bevantolol in patients with coronary artery disease: a placebo-controlled, randomized, double-blind study.
Gimeno JV; Ferrer J; Olague J; Bordes P; Serra J; Estruch G; Mainer V; Algarra FJ
Clin Cardiol; 1986 Sep; 9(9):457-60. PubMed ID: 3530572
[TBL] [Abstract][Full Text] [Related]
9. Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
Lammers JW; Folgering HT; van Herwaarden CL
Eur J Clin Pharmacol; 1984; 27(2):141-5. PubMed ID: 6149939
[TBL] [Abstract][Full Text] [Related]
10. Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma.
Wilcox PG; Ahmad D; Darke AC; Parsons J; Carruthers SG
Clin Pharmacol Ther; 1986 Jan; 39(1):29-34. PubMed ID: 3943267
[TBL] [Abstract][Full Text] [Related]
11. Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort.
Molajo AO; Bray CL; Hillier V
Int J Cardiol; 1989 Nov; 25(2):185-92. PubMed ID: 2572566
[TBL] [Abstract][Full Text] [Related]
12. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
13. Ventilatory and haemodynamic effects of terbutaline infusion during beta 1-selective blockade with metoprolol and acebutolol in asthmatic patients.
Greefhorst AP; van Herwaarden CL
Eur J Clin Pharmacol; 1982; 23(3):203-8. PubMed ID: 6756931
[TBL] [Abstract][Full Text] [Related]
14. Effect of prenalterol in asthmatic patients.
Löfdahl CG; Svedmyr N
Eur J Clin Pharmacol; 1982 Oct; 23(4):297-302. PubMed ID: 6129142
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of bevantolol hydrochloride towards alpha- and beta-adrenoceptor subtypes in rat cerebral cortex.
Takita M; Kigoshi S; Muramatsu I
Jpn J Pharmacol; 1992 Feb; 58(2):193-6. PubMed ID: 1354761
[TBL] [Abstract][Full Text] [Related]
16. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
17. A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients.
Lammers JW; Müller ME; Folgering HT; van Herwaarden CL
Br J Clin Pharmacol; 1986 Nov; 22(5):595-602. PubMed ID: 2878680
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-adrenoceptor antagonist, in dogs.
Hino T; Sakai K; Ichihara K; Abiko Y
Pharmacol Toxicol; 1989 Apr; 64(4):324-8. PubMed ID: 2568629
[TBL] [Abstract][Full Text] [Related]
19. Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
Maclean D
Angiology; 1988 Jun; 39(6):487-96. PubMed ID: 2897812
[TBL] [Abstract][Full Text] [Related]
20. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
Tattersfield AE; Cragg DJ; Bacon RJ
Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
